INS and cancer: According to ASCO guidelines, pharmacologic approaches of interest for cancer cachexia are appetite stimulants (cannabis and cannabinoids, corticosteroids, cyproheptadine, and megestrol acetate), anabolic agents (anamorelin, androgens, or selective androgen receptor modulators), cytokine inhibitors (hydrazine sulfate, thalidomide, and tumor necrosis factor inhibitors), and others [adenosine triphosphate, insulin, mirtazapine, melatonin, nonsteroidal anti-inflammatory agents (NSAIDS), and olanzapine] (Roeland et al., 2020; Roeland et al., 2023).